Cell-based assays are a critical component of drug discovery and development, providing valuable information about the efficacy, toxicity, and safety of potential therapeutics.
At Krems Bioanalytics, we offer cell-based assays performed under Good Laboratory Practice (GLP) guidelines – and soon under Good Manufacturing Practice (GMP) guidelines – ensuring the highest standards of accuracy, reproducibility, and compliance with regulatory requirements.
Supporting your drug candidate assessment
Our cell-based assays can help you assess the potency and specificity of your drug candidates, evaluate their potential toxicity and side effects, and identify optimal dosing regimens. We provide a wide range of cell-based assays including viability assays, proliferation assays and apoptosis assays.
Contact us today to learn more about how our cell-based assay services can support your programme.